The study is about testing a new way to prepare patients for a special kind of stem-cell transplant called HSCT (Hematopoietic Stem-Cell Transplantation). This new method, called TMLI (Total Marrow and Lymphoid Irradiation), uses radiation to help the body accept new cells without harming healthy tissues. This is important for patients aged 16 to 45 with a type of blood cancer called ALL (Acute Lymphoblastic Leukemia) that has either returned or didn't respond to initial treatment.
The study will check if TMLI is safe and works well. TMLI is part of a treatment plan that also includes drugs like fludarabine and cyclophosphamide. Patients will receive radiation and then new healthy cells to help fight the cancer. Doctors will watch how the patients do after the procedure to see how well it works.
NCT06209190
Hospital Universitario Dr. Jose E. Gonzalez
24 January 2024
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Congrats! You have your own personal workspace now.